Literature DB >> 1093421

Protection of the ischemic liver by donor pretreatment before transplantation.

L H Toledo-Pereyra, R L Simmons, J S Najarian.   

Abstract

Canine livers ischemically damaged for thirty minutes prior to auxiliary transplantation did not survive for long periods of time unless a combination of isoproterenol, allopurinol, and heparin was administered intravenously to the donor animal before the ischemic damage. These drugs had no protective effect when given individually. Ischemic livers treated with adenosine prior to transplantation also showed no improved recovery of function.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1093421     DOI: 10.1016/0002-9610(75)90308-6

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  12 in total

Review 1.  Liver transplantation reperfusion injury. Factors in its development and avenues for treatment.

Authors:  L H Toledo-Pereyra
Journal:  Klin Wochenschr       Date:  1991-12-15

2.  Protective effect of lipopolysaccharide preconditioning in hepatic ischaemia reperfusion injury.

Authors:  Takanori Sano; Kunihiko Izuishi; Mohammad A Hossain; Keitaro Kakinoki; Keiichi Okano; Tsutomu Masaki; Yasuyuki Suzuki
Journal:  HPB (Oxford)       Date:  2010-09-02       Impact factor: 3.647

Review 3.  Therapeutic modulation of free radical-mediated reperfusion injury of the liver and its surgical implications.

Authors:  S Marubayashi; K Dohi
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

4.  Calcium antagonist prevents calcium flux induced necrosis and apoptosis in ischemic reperfusion of rat liver.

Authors:  Pronobesh Chattopadhyay; Nevneet Verma; Anurag Verma; Gunjan Shukla; Arun Kumar Wahi
Journal:  Indian J Clin Biochem       Date:  2008-12-20

5.  Protective effects of spironolactone against hepatic ischemia/reperfusion injury in rats.

Authors:  Süleyman Atalay; Belkıs Soylu; Aslı Aykaç; Ayliz Velioğlu Öğünç; Şule Çetinel; Naziye Özkan; Can Erzik; Ahmet Özer Şehirli
Journal:  Turk J Surg       Date:  2019-12-16

6.  N-acetylcysteine attenuates ischemia-reperfusion-induced apoptosis and autophagy in mouse liver via regulation of the ROS/JNK/Bcl-2 pathway.

Authors:  Chengfen Wang; Kan Chen; Yujing Xia; Weiqi Dai; Fan Wang; Miao Shen; Ping Cheng; Junshan Wang; Jie Lu; Yan Zhang; Jing Yang; Rong Zhu; Huawei Zhang; Jingjing Li; Yuanyuan Zheng; Yingqun Zhou; Chuanyong Guo
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

7.  Intestinal translocation of clinical isolates of vancomycin-resistant Enterococcus faecalis and ESBL-producing Escherichia coli in a rat model of bacterial colonization and liver ischemia/reperfusion injury.

Authors:  Karin M van der Heijden; Inneke M van der Heijden; Flavio H Galvao; Camila G Lopes; Silvia F Costa; Edson Abdala; Luiz A D'Albuquerque; Anna S Levin
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

8.  Trisulfate Disaccharide Decreases Calcium Overload and Protects Liver Injury Secondary to Liver Ischemia/Reperfusion.

Authors:  Enio Rodrigues Vasques; Jose Eduardo Monteiro Cunha; Ana Maria Mendonca Coelho; Sandra N Sampietre; Rosely Antunes Patzina; Emilio Elias Abdo; Helena B Nader; Ivarne L S Tersariol; Marcelo Andrade Lima; Carlos M G Godoy; Tiago Rodrigues; Eleazar Chaib; Luiz A C D'Albuquerque
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

9.  Carvacrol alleviates ischemia reperfusion injury by regulating the PI3K-Akt pathway in rats.

Authors:  Lida Suo; Kai Kang; Xun Wang; Yonggang Cao; Haifeng Zhao; Xueying Sun; Liquan Tong; Feng Zhang
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

10.  Limb remote ischemic conditioning of the recipient protects the liver in a rat model of arterialized orthotopic liver transplantation.

Authors:  Zoltan Czigany; Christian Bleilevens; Christian Beckers; Christian Stoppe; Michaela Möhring; Andras Fülöp; Attila Szijarto; Georg Lurje; Ulf P Neumann; René H Tolba
Journal:  PLoS One       Date:  2018-04-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.